Biolevate has raised €30 million in Series A funding co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F and existing investor EQT Ventures. The company plans to use the capital to scale its enterprise agentic AI platform for life sciences and expand into the US market.
The platform automates scientific and regulatory workflows, achieving a sixteenfold acceleration in systematic literature reviews and an